Form 4 for GH Guardant Health, Inc.
Accepted 2026-06-22 17:53:00 ET · period of report 2026-06-17 · accession 0001770749-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-22 17:53 | 2026-06-17 | GH | Joyce Meghan V. | Dir | M - OptEx | $0.00 | +4,203 | 15.4K | +38% | $0 |
| D | 2026-06-22 17:53 | 2026-06-17 | GH | Joyce Meghan V. | Dir | M - OptEx | $0.00 | -4,203 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-17 | M | A | 4,203 | $0.00 | 15,386 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2026-06-17 | M | D | 4,203 | $0.00 | 0 | D | $0.00 · — to — | 4,203 Common Stock | (F1) The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. (F2) Not applicable for Restricted Stock Units. |